Hematoxylin-eosin (HE) staining of the tissues demonstrated that PD-L1 blockade-treated mice have much reduced area of lung adenocarcinoma (Fig. 2l) and less lesions (Fig. 2k) and decreased PD-L1+ lung cancer cells (Fig. 2m). This evidence concerns the gene CD274 and lung carcinoma.